中文 | English
Return
Total: 157 , 1/16
Show Home Prev Next End page: GO
Author:(Yanbo ZHANG)

1.Mitogen-activated proteins kinases:an emerging therapeutic target for pathological pain

Yanbo ZHANG ; Guowei LV

Chinese Pharmacological Bulletin 2003;0(07):-

2.Effect of Indomethacin suppositories on albumin concentration and insulin resistance of post-operation patients with serious intra-abdominal infection

Feng SHAO ; Yanbo ZHANG

Chinese Journal of Current Advances in General Surgery 1999;0(04):-

3.Analysis on the results of foodborne disease surveillance in Baiyin City, Gansu Province, 2015

Yanbo WANG ; Xiaomei ZHANG

Chinese Journal of Food Hygiene 2017;29(4):488-491

4.Serum biomarkers of outcome in acute ischemic stroke

Yanbo HE ; Yan ZHANG

International Journal of Cerebrovascular Diseases 2017;25(5):460-467

5.Mitogen-activated proteins kinases pathway and pathological pain sensitization

Yanbo ZHANG ; Jingzhong NIU ; Baoliang SUN

Chinese Journal of Pathophysiology 2010;26(3):613-616

6.Neuroprotective effects of rhG-CSF on brain given intranasal in cerebral infarct rats

Meiqing HE ; Baoliang SUN ; Yanbo ZHANG

Chinese Journal of Behavioral Medicine and Brain Science 2009;18(6):532-534

7.Analysis on Characteristic Peaks of Gypsum Fibrosum from Authentic Product Area Hubei Yingcheng by X-ray Diffraction

Yanbo FAN ; Weijun LIANG ; Yisheng ZHANG

China Pharmacist 2015;(5):775-777

8.The Research Advance in the Relation between Hypertension and Diets

Lina WANG ; Yanbo ZHANG ; Guiwen SHI

Chinese Journal of Prevention and Control of Chronic Diseases 2006;0(01):-

9.Study on Extraction Technology for Water Extract of Tangganjian Concentrated Pills

Ying WU ; Yisheng ZHANG ; Yanbo FAN

China Pharmacist 2016;19(7):1236-1238

10.Clinical observation of mirtazapine in the treatment of somatoform disorders

Xueqing HAN ; Yajuan NIU ; Yanbo ZHANG

Chinese Journal of Primary Medicine and Pharmacy 2013;20(14):2163-2164

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 157 , 1/16 Show Home Prev Next End page: GO